Key result
AAV9-mediated LMNA re-expression extends median survival from 28 to 52 days in Lmna-deficient mice.
Why the study?
The genes and regulatory pathways controlled by LMNA in the heart are not completely defined, despite LMNA mutations causing dilated cardiomyopathies (laminopathies).
Does AAV9-mediated LMNA re-expression restore dysregulated cardiac genes, improve cardiac function, and increase survival in Lmna-/- mice?
Does AAV9-mediated LMNA re-expression restore dysregulated cardiac genes, improve cardiac function, and increase survival in Lmna-/- mice?
This study identifies lysine-specific demethylases 5A and 5B as potential epigenetic therapeutic targets in LMNA-associated heart failure.
LMNA re-expression extends survival in Lmna-/- mice; hypothesis-generating for KDM5A/B targeting in human laminopathy cardiomyopathy.
Background Mutations in the LMNA gene, encoding LMNA (lamin A/C), causes distinct disorders, including dilated cardiomyopathies, collectively referred to as laminopathies. The genes (coding and noncoding) and regulatory pathways controlled by LMNA in the heart are not completely defined. Methods and Results We analyzed cardiac transcriptome from wild‐type, loss‐of‐function ( Lmna −/− ), and gain‐of‐function ( Lmna −/− injected with adeno‐associated virus serotype 9 expressing LMNA) mice with normal cardiac function. Deletion of Lmna ( Lmna −/− ) led to differential expression of 2193 coding and 629 long noncoding RNA genes in the heart (q<0.05). Re‐expression of LMNA in the Lmna −/− mouse heart, completely rescued 501 coding and 208 non‐coding and partially rescued 1862 coding and 607 lncRNA genes. Pathway analysis of differentially expressed genes predicted activation of transcriptional regulators lysine‐specific demethylase 5A, lysine‐specific demethylase 5B, tumor protein 53, and suppression of retinoblastoma 1, paired‐like homeodomain 2, and melanocyte‐inducing transcription factor, which were completely or partially rescued upon reexpression of LMNA. Furthermore, lysine‐specific demethylase 5A and 5B protein levels were increased in the Lmna −/− hearts and were partially rescued upon LMNA reexpression. Analysis of biological function for rescued genes identified activation of tumor necrosis factor‐α, epithelial to mesenchymal transition, and suppression of the oxidative phosphorylation pathway upon Lmna deletion and their restoration upon LMNA reintroduction in the heart. Restoration of the gene expression and transcriptional regulators in the heart was associated with improved cardiac function and increased survival of the Lmna −/− mice. Conclusions The findings identify LMNA‐regulated cardiac genes and their upstream transcriptional regulators in the heart and implicate lysine‐specific demethylase 5A and B as epigenetic regulators of a subset of the dysregulated genes in laminopathies.
No takes yet. Share an insight, caveat, or question.
Pradas et al. (2020) studied LMNA mutation-associated dilated cardiomyopathy (laminopathies). Adeno-associated virus serotype 9 expressing wild-type LMNA vs. Empty AAV9 vector or untreated Lmna-/- mice was evaluated on Differential gene expression, pathway activation, and survival. Re-expression of LMNA in Lmna-/- mouse hearts rescued thousands of dysregulated genes, partially normalized lysine-specific demethylase 5A and 5B levels, and increased median survival from 28 to 52 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: